Experimental drugs for treatment of autoimmune myocarditis

Li Na Han, Shu Li Guo, Yu Tang Wang, Li Ming Yang, Si Yu Liu

科研成果: 期刊稿件文献综述同行评审

7 引用 (Scopus)

摘要

Objective: To review the experimental drugs for the treatment of autoimmune myocarditis. Data sources: The literatures published in English about different kinds of experimental drugs based on different therapeutic mechanisms for the treatment of autoimmune myocarditis were obtained from PubMed from 2002 to 2013. Study selection: Original articles regarding the experimental drugs for treatment of autoimmune myocarditis were selected. Results: This study summarized the effects of the experimental drugs for the treatment of autoimmune myocarditis, such as immunomodulators and immunosuppressants, antibiotics, Chinese medicinal herbs, cardiovascular diseases treatment drugs, etc. These drugs can significantly attenuate autoimmune myocarditis-induced inflammation and fibrosis, alleviate autoimmune myocarditis-triggered overt lymphocyte proliferation, and meanwhile reduce Th1 cytokines (IFN-γ and IL-2) and increase Th2 cytokines (IL-4 and IL-10). Conclusion: This study summarized recent advances in autoimmune myocarditis treatment and further proposes that traditional Chinese medicine and immune regulators will play important roles in the future.

源语言英语
页(从-至)2850-2859
页数10
期刊Chinese Medical Journal
127
15
DOI
出版状态已出版 - 2014
已对外发布

指纹

探究 'Experimental drugs for treatment of autoimmune myocarditis' 的科研主题。它们共同构成独一无二的指纹。

引用此